Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001723128-25-000040
Filing Date
2025-08-05
Accepted
2025-08-05 16:39:08
Documents
12
Period of Report
2025-08-05
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K/A amrx-20250805.htm   iXBRL 8-K/A 25589
  Complete submission text file 0001723128-25-000040.txt   141579

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amrx-20250805.xsd EX-101.SCH 1876
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amrx-20250805_lab.xml EX-101.LAB 21885
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amrx-20250805_pre.xml EX-101.PRE 12599
14 EXTRACTED XBRL INSTANCE DOCUMENT amrx-20250805_htm.xml XML 2732
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38485 | Film No.: 251185624
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)